Cargando…

AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization

We here present AutoGrow4, an open-source program for semi-automated computer-aided drug discovery. AutoGrow4 uses a genetic algorithm to evolve predicted ligands on demand and so is not limited to a virtual library of pre-enumerated compounds. It is a useful tool for generating entirely novel drug-...

Descripción completa

Detalles Bibliográficos
Autores principales: Spiegel, Jacob O., Durrant, Jacob D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165399/
https://www.ncbi.nlm.nih.gov/pubmed/33431021
http://dx.doi.org/10.1186/s13321-020-00429-4
_version_ 1783523469571391488
author Spiegel, Jacob O.
Durrant, Jacob D.
author_facet Spiegel, Jacob O.
Durrant, Jacob D.
author_sort Spiegel, Jacob O.
collection PubMed
description We here present AutoGrow4, an open-source program for semi-automated computer-aided drug discovery. AutoGrow4 uses a genetic algorithm to evolve predicted ligands on demand and so is not limited to a virtual library of pre-enumerated compounds. It is a useful tool for generating entirely novel drug-like molecules and for optimizing preexisting ligands. By leveraging recent computational and cheminformatics advancements, AutoGrow4 is faster, more stable, and more modular than previous versions. It implements new docking-program compatibility, chemical filters, multithreading options, and selection methods to support a wide range of user needs. To illustrate both de novo design and lead optimization, we here apply AutoGrow4 to the catalytic domain of poly(ADP-ribose) polymerase 1 (PARP-1), a well characterized DNA-damage-recognition protein. AutoGrow4 produces drug-like compounds with better predicted binding affinities than FDA-approved PARP-1 inhibitors (positive controls). The predicted binding modes of the AutoGrow4 compounds mimic those of the known inhibitors, even when AutoGrow4 is seeded with random small molecules. AutoGrow4 is available under the terms of the Apache License, Version 2.0. A copy can be downloaded free of charge from http://durrantlab.com/autogrow4. [Image: see text]
format Online
Article
Text
id pubmed-7165399
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-71653992020-04-22 AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization Spiegel, Jacob O. Durrant, Jacob D. J Cheminform Software We here present AutoGrow4, an open-source program for semi-automated computer-aided drug discovery. AutoGrow4 uses a genetic algorithm to evolve predicted ligands on demand and so is not limited to a virtual library of pre-enumerated compounds. It is a useful tool for generating entirely novel drug-like molecules and for optimizing preexisting ligands. By leveraging recent computational and cheminformatics advancements, AutoGrow4 is faster, more stable, and more modular than previous versions. It implements new docking-program compatibility, chemical filters, multithreading options, and selection methods to support a wide range of user needs. To illustrate both de novo design and lead optimization, we here apply AutoGrow4 to the catalytic domain of poly(ADP-ribose) polymerase 1 (PARP-1), a well characterized DNA-damage-recognition protein. AutoGrow4 produces drug-like compounds with better predicted binding affinities than FDA-approved PARP-1 inhibitors (positive controls). The predicted binding modes of the AutoGrow4 compounds mimic those of the known inhibitors, even when AutoGrow4 is seeded with random small molecules. AutoGrow4 is available under the terms of the Apache License, Version 2.0. A copy can be downloaded free of charge from http://durrantlab.com/autogrow4. [Image: see text] Springer International Publishing 2020-04-17 /pmc/articles/PMC7165399/ /pubmed/33431021 http://dx.doi.org/10.1186/s13321-020-00429-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Software
Spiegel, Jacob O.
Durrant, Jacob D.
AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization
title AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization
title_full AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization
title_fullStr AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization
title_full_unstemmed AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization
title_short AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization
title_sort autogrow4: an open-source genetic algorithm for de novo drug design and lead optimization
topic Software
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165399/
https://www.ncbi.nlm.nih.gov/pubmed/33431021
http://dx.doi.org/10.1186/s13321-020-00429-4
work_keys_str_mv AT spiegeljacobo autogrow4anopensourcegeneticalgorithmfordenovodrugdesignandleadoptimization
AT durrantjacobd autogrow4anopensourcegeneticalgorithmfordenovodrugdesignandleadoptimization